Showing results (691-700 of 1,074) with videos related to
Sort By:
Pageof 108
Journal of Cardiovascular Translational Research|December 28, 2013
Randomized comparison of ticagrelor versus prasugrel in patients with acute coronary syndrome and planned invasive strategy--design and rationale of the iNtracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5 trialStefanie Schulz, Dominick J Angiolillo, David Antoniucci, et al.The Journal of Invasive Cardiology|July 3, 2009
Long-term outcomes comparison of different types of DES in elderly patients from a real-world experienceAlessandra Sanfilippo, Miriam Cumbo, Anna Maria Caggegi, et al.The American Journal of Cardiology|May 20, 2014
A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacementDavide Capodanno, Marco Barbanti, Corrado Tamburino, et al.Circulation. Cardiovascular Interventions|November 3, 2016
Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 UpdateDominick J Angiolillo, Shaun G Goodman, Deepak L Bhatt, et al.Journal of the American College of Cardiology|February 15, 2020
Ticagrelor With or Without Aspirin After PCI: The TWILIGHT Platelet SubstudyUsman Baber, M Urooj Zafar, George Dangas, et al.Circulation. Cardiovascular Interventions|April 11, 2018
Incidence, Predictors, and Outcomes of Acquired Thrombocytopenia After Percutaneous Coronary Intervention: A Pooled, Patient-Level Analysis of the CHAMPION Trials (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition)Elliott M Groves, Deepak L Bhatt, Philippe Gabriel Steg, et al.Heart (British Cardiac Society)|February 6, 2016
Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary interventionMatthijs A Velders, Jérémie Abtan, Dominick J Angiolillo, et al.European Heart Journal. Cardiovascular Pharmacotherapy|June 11, 2021
Impact of chronic kidney disease on the pharmacodynamic and pharmacokinetic effects of ticagrelor in patients with diabetes mellitus and coronary artery diseaseFrancesco Franchi, Fabiana Rollini, Latonya Been, et al.Journal of Thrombosis and Thrombolysis|June 14, 2017
Platelet-related biomarkers and their response to inhibition with aspirin and p2y12-receptor antagonists in patients with acute coronary syndromeAngela Lowenstern, Robert F Storey, Megan Neely, et al.JACC. Cardiovascular Interventions|November 1, 2022
Cangrelor in Patients With Coronary Artery Disease Pretreated With Ticagrelor: The Switching Antiplatelet (SWAP)-5 StudyFrancesco Franchi, Luis Ortega-Paz, Fabiana Rollini, et al.Pageof 108